The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: sodium rabeprazole ranitidine hydrochloride CONDITION: The patients of GERD with chronic liver disease PRIMARY OUTCOME: The symptons of upper gastrointestine evaluated by F‐sacle SECONDARY OUTCOME: The symptons by SF‐8; gastrointesitinal peptide INCLUSION CRITERIA: The patients evaluated by F‐scale The patients evaluated by SF‐8 The patients without gastric ulcer or duodenal ulcer The patients with chronic liver disease
Epistemonikos ID: 107e4e2e2fda068a0c5d0de9cd56f341d8f9dc98
First added on: Aug 22, 2024